Karat Packaging Inc. filed a Form 8-K with the SEC on November 4, 2026, disclosing that its Board of Directors declared a regular quarterly cash dividend of $0.47 per share on the company's common stock.
Annovis Bio, Inc. filed a Form 8-K on November 4, 2026, disclosing that stockholders approved an amendment to the company's Amended and Restated Certificate of Incorporation at a Special Meeting held telephonically on November 3, 2026, doubling authorized common shares from 70,000,000 to 140,000,000.
Annovis Bio, Inc. filed a Form 8-K on November 4, 2026, disclosing a preliminary, unaudited estimate that its cash and cash equivalents were approximately $2.8 million as of September 30, 2026.
SmartStop Self Storage REIT, Inc. filed a Current Report on Form 8-K on November 4, 2026, disclosing that it issued a press release on the same date announcing its financial results for the three and nine months ended September 30, 2026.
Emergent BioSolutions Inc. filed a Form 8-K on November 4, 2026, disclosing a contract modification exercising an option period to supply BioThrax (Anthrax Vaccine Adsorbed) to the U.S. Department of War for a value of up to $22.3 million.
Pacific Biosciences of California, Inc. filed an 8-K on November 4, 2026, disclosing a Chief Financial Officer transition effective November 3, 2026, the appointment of an interim CFO, and the appointment of a new Chief Accounting Officer, alongside the announcement of third-quarter 2026 financial …
Veracyte, Inc. filed a Form 8-K on November 4, 2026, disclosing the commencement of a Board-authorized share repurchase program and announcing financial results for the quarter ended September 30, 2026.
Barrett Business Services, Inc. filed an 8-K on November 4, 2026, disclosing its third-quarter financial results for the period ended September 30, 2026, and announcing a regular quarterly cash dividend of $0.08 per share.
Monro, Inc. filed an 8-K on November 4, 2026, disclosing an amendment to its existing Rights Agreement that extends the plan's final expiration date by approximately one year to November 1, 2027.
Matson, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on November 4, 2026, announcing the company's earnings results for the quarter ended September 30, 2026.